期刊文献+

经瞳孔温热疗法治疗湿性年龄相关性黄斑变性的参数研究 被引量:2

Power setting of transpupillary thermotherapy for patients with age-related macular degenera-tion
原文传递
导出
摘要 目的评价三种不同参数的经瞳孔温热疗法(transpupillarythermotherapy,TTT)治疗湿性年龄相关性黄斑变性(age-relatedmaculardegeneration,ARMD)的疗效。方法2002年4月~2005年1月在我科确诊为ARMD渗出型患者24例32眼,男性17例25眼,女性7例7眼,年龄47~84岁(平均67.96岁)。其中17位患者(隐匿性CNV9眼、典型性及典型性为主型10眼)接受TTT治疗,按采取的能量参数分为100%能量组(7眼)、80%能量组(5眼)、70%能量组(7眼),其余7例13眼不接受任何治疗手段的患者作为无治疗组列为观察对象。术后对眼底改变、视力、眼底血管造影复查,随访6~37个月(平均21.65个月)观察疗效并进行统计分析。结果至末次复查时所有接受TTT治疗的19只患眼的出血、水肿、渗出消失、病灶斑痕化。100%能量组,80%能量组以及70%能量组视力提高的患眼比例相比较,均无统计学显著差异(分别为p=0.523,p=1.000,p=1.000)。治疗组(包括100%能量组,80%能量组以及70%能量组)与无治疗组视力下降的患眼比例相比较,有统计学显著差异(p=0.002)。治疗组与无治疗组视力提高的患眼比例相比较,无统计学显著差异(p=0.361)。结论TTT对隐匿型和经典型CNV均有稳定患眼视力的作用。目前选择该研究中80%能量组的参数,可以在安全性和有效性上得到进一步完善,仍有待更多病例的证实。 Objective To evaluate the clinical effect of transpupillary thermotherapy(TTT) with three different power settings. Methods Four groups were followed up 6-37 months(average 21.65 months). They are 100% power group(7 eyes), 80% power group(5 eyes),70% power group(7 eyes) and no treatment group(13 eyes). The visual acuity, complications,fundus image and FFA/ICGA were observed pre- and postoperatively. Results The retinal hemorrhage and leakage of CNV were completely absorbed after TTT in all eyes.The ratio of improved visual acuity between 100% power group,80% power group and 70% power group showed no statistic significance(p=0.523, p=1.000, p=1.000).However, The ratio of decreased but not improved visual acuity between TIT group(include 100% power group,80% power group and 70% power group) and no treatment group has statistic significance (p=0.002). Conclusion TTT prevents the decrease of visual acuity in patients with occult and classic CNV caused by ARMD.The power setting of 80% power group seems more safe and effective.More cases and long term observation are needed.
出处 《中国实用眼科杂志》 CSCD 北大核心 2006年第9期976-978,共3页 Chinese Journal of Practical Ophthalmology
基金 南通市科技局社会发展基金资助(编号:S2004)
关键词 经瞳孔温热疗法(TTT) 年龄相关性黄斑变性(ARMD) 剂量 Transpupillary thermotherapy (TIT) age-related macular degeneration(ARMD) dosage
  • 相关文献

参考文献6

二级参考文献22

  • 1Reichel E, Berrocal AM,Ip M, et al. Transpupillary ther-motherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration.Ophthalmology, 1999,106:1908-1914. 被引量:1
  • 2Newsom RS, McAlister JC, Saeed M, et al. Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularisation.Br J Ophthalmol, 2001,85:173-178. 被引量:1
  • 3Thompson JT. Retinal pigment epithelial tear after transpupillary thermotherapy for choroidal neovascularization. Am J Ophthalmol, 2001,131:662-664. 被引量:1
  • 4Mainster MA, Reichel E. Thanspupillary thermotherapy for age-related macular degeneration: long-pulse photocoagulation, apoptosis,and heat shock proteins. Ophthalmic Surgery and Lasers, 2000,31: 359-373. 被引量:1
  • 5Desmettre T, Maurage CA, Mordon S. Heat shock protein hyperexpression on chorioretinal layers after transpupillary thermotherapy. Invest Ophthalmol Vis Sci, 2001,42:2976-2980. 被引量:1
  • 6Oosterhuis JA, Journee-de Korver HG, Kakebeeke-Kemme HM. Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol, 1995,113:315-321. 被引量:1
  • 7Stevens TS,Bressler NM,Maguire MG,et al.Occult choroidal neovascularization in age- related macular degeneration: a natural history study. Arch Ophthalmol, 1997,115:345-350. 被引量:1
  • 8Bressler NM,Frest LA,Sorenson JA, et al.Natural course of poorly defined choroidal neovascularization associated with macular degeneration. Arch Ophthalmol, 1988,106: 1537-1542. 被引量:1
  • 9Macular Photocoagulation Study Group. Occult choroidal neovascularization:influence on visual outcome in patients with age- related macular degeneration. Arch Ophthalmol, 1996,114:400-412. 被引量:1
  • 10Kaga T, Fonseca RA, Dantas MA,et al. Transpupillary thermotherapy for occult choroidal neovascularization.Retina, 2001,21:172-173. 被引量:1

共引文献32

同被引文献18

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部